Summary by Futu AI
PuraPharm Corporation announced that Mr. Chi Ka Chi will resign from his position as an independent non-executive director, chairman of the audit committee, and member of the remuneration committee on June 21, 2024. Mr. Chi stated that his resignation was to focus on personal pursuits and was not due to any disagreement with the Board of Directors. The Board of Directors expressed their gratitude for Mr. Chi's contributions during his tenure. With Mr. Chi's departure, Dr. Yip Siu Ping and Dr. Albert R. Collinson will take over his positions on the committee. However, Mr. Chi's resignation has temporarily caused the company to fail to meet the professional qualifications required by the Listing Rules of the Hong Kong Stock Exchange for independent non-executive directors. The company is looking for suitable candidates to comply with relevant regulations and will make appropriate personnel adjustments within three months.